3-(pyrrolidin-2-yl)pyridine; 3-(2-Pyrrolidinyl)pyridine; 3-pyrrolidin-2-ylpyridine; (R,S)-Nornicotine; (+-)-Nornicotine; 2-(3-Pyridyl)pyrrolidine; 3-pyrrolidin-2-yl-pyridine; (+/-)-Nornicotine; 3-(2-Pyrrolidyl)pyridine; (+-)-1'-Demethylnicotine; DL-NORNICOTINE; (+-)-3-(2-Pyrrolidinyl)pyridine; (RS)-nornicotine; MFCD00016913; DL-2-(3-PYRIDYL)PYRROLIDINE; CHEMBL1132; SMR000449277; (+/-)Nornicotine; (S)-2-(3-Pyridyl)pyrrolidine; (S)-3-Pyrrolidin-2-yl-pyridine; rac-Nornicotine; dl-Norcitine; Pyridine, 3-(2-pyrrolidinyl)-, (S)-; Nicotine, 1'-demethyl-, (+-)-; Nornicotine, 97%; .beta.-dl-Nornicotine; PubChem15004; PubChem16040; ACMC-1BBGF; (.+/-.)-Nornicotine; Nicotine Related Compound F; (+/-)-Nornicotine solution; KSC495K0B; MLS000758240; MLS001424032; (+-)-1'-demethyl-Nicotine; SCHEMBL158145; 3-(pyrolidin-2-yl)-pyridine; SCHEMBL13090363; AMPD00301; CTK3J5500; (.+/-.)-1'-Demethylnicotine; 3-Pyrrolidin-2-ylpyridine, 95%; HMS2051O11; HMS2232N03; HMS3372K03; HMS3393O11; 2-(3-PYRIDINYL)PYRROLIDINE; 3,3,4,4-Isophthaloydiphthalicacid; 8459AB; ANW-49652; AR1067; BBL004930; BDBM50023328; STL139255; AKOS001428655; AKOS016050380; AB01223; ACN-049240; CCG-100790; CS-W002112; GF-0112; MCULE-5742121668; NC00040; SB37747; VP14443; NCGC00163364-01; Nicotine, 1'-demethyl-, (.+/-.)-; AC-10074; AK-30521; AK-75905; BR-30521; SC-29443; SY023448; AB0052616; DB-021745; AM20061865; BB 0249476; FT-0635832; FT-0673119; ST50824149; EN300-23749; (+/-)-Nornicotine, >=98% (TLC), liquid; B-1538; C06524; Pyridine, 3-(2-pyrrolidinyl)-, (.+/-.)-; 746N861; Pyridine, 3-(2-pyrrolidinyl)-, (+-)- (9CI); Q907939; J-510969; 3-[(2RS)-Pyrrolidin-2-yl]pyridine ((RS)-Nornicotine); Z278210538